Mn Services Vermogensbeheer B.V. Has $48.39 Million Stake in Stryker Corporation $SYK

Mn Services Vermogensbeheer B.V. increased its stake in Stryker Corporation (NYSE:SYK) by 1.9% in the third quarter, Holdings Channel.com reports. The firm owned 130,900 shares of the medical technology company’s stock after purchasing an additional 2,500 shares during the quarter. Mn Services Vermogensbeheer B.V.’s holdings in Stryker were worth $48,390,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank acquired a new position in shares of Stryker during the second quarter worth about $1,882,173,000. Alliancebernstein L.P. raised its position in Stryker by 307.6% in the 2nd quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company’s stock valued at $2,214,146,000 after buying an additional 4,223,366 shares during the last quarter. Corient Private Wealth LLC lifted its stake in Stryker by 104.4% in the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after acquiring an additional 1,146,998 shares in the last quarter. ABN AMRO Bank N.V. bought a new stake in Stryker in the 2nd quarter valued at approximately $191,047,000. Finally, Vanguard Group Inc. boosted its position in Stryker by 1.3% during the 2nd quarter. Vanguard Group Inc. now owns 33,500,571 shares of the medical technology company’s stock worth $13,253,831,000 after acquiring an additional 440,607 shares during the last quarter. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Evercore ISI set a $390.00 price objective on shares of Stryker in a research report on Monday, January 5th. Sanford C. Bernstein boosted their price target on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research report on Friday, January 9th. Citizens Jmp upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 price objective for the company in a report on Friday, December 19th. Wall Street Zen upgraded Stryker from a “hold” rating to a “buy” rating in a report on Sunday, December 21st. Finally, Wells Fargo & Company increased their price target on Stryker from $452.00 to $456.00 and gave the company an “overweight” rating in a research report on Friday, November 14th. Fourteen research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $430.00.

Stryker Stock Down 1.1%

Shares of SYK stock opened at $354.74 on Friday. Stryker Corporation has a 52-week low of $329.16 and a 52-week high of $406.19. The stock has a market cap of $135.66 billion, a price-to-earnings ratio of 46.62, a PEG ratio of 2.30 and a beta of 0.89. The firm’s 50-day moving average is $359.77 and its 200-day moving average is $372.93. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.13 and a current ratio of 1.85.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 EPS for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. The business had revenue of $6.06 billion during the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a return on equity of 24.07% and a net margin of 12.07%.Stryker’s quarterly revenue was up 10.2% on a year-over-year basis. During the same quarter last year, the company posted $2.87 earnings per share. Sell-side analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Wednesday, December 31st will be issued a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, December 31st. This is a boost from Stryker’s previous quarterly dividend of $0.84. Stryker’s payout ratio is presently 46.25%.

Insider Activity at Stryker

In other Stryker news, Director Ronda E. Stryker sold 276,173 shares of the company’s stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $353.28, for a total value of $97,566,397.44. Following the transaction, the director directly owned 2,702,108 shares in the company, valued at $954,600,714.24. The trade was a 9.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Preston Wendell Wells sold 165 shares of the stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the completion of the transaction, the chief financial officer directly owned 6,694 shares in the company, valued at $2,449,200.72. The trade was a 2.41% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 522,118 shares of company stock worth $185,381,932. Company insiders own 5.90% of the company’s stock.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.